Calliditas Therapeutics AB
STO:CALTX

Watchlist Manager
Calliditas Therapeutics AB Logo
Calliditas Therapeutics AB
STO:CALTX
Watchlist
Price: 208 SEK 0.87%
Market Cap: 12.5B SEK
Have any thoughts about
Calliditas Therapeutics AB?
Write Note

Wall Street
Price Targets

CALTX Price Targets Summary
Calliditas Therapeutics AB

There are no price targets for CALTX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Calliditas Therapeutics AB Competitors:
Price Targets
1666
Tong Ren Tang Technologies Co Ltd
28% Upside
603566
Pulike Biological Engineering Inc
15% Upside
SUNPHARMA
Sun Pharmaceutical Industries Ltd
13% Upside
PPLPHARMA
Piramal Pharma Ltd
16% Upside
BSEM
Biostem Technologies Inc
151% Upside
SNT
Syntara Ltd
83% Upside
300558
Betta Pharmaceuticals Co Ltd
7% Upside
600993
Mayinglong Pharmaceutical Group Co Ltd
46% Upside

Revenue
Forecast

Revenue Estimate
Calliditas Therapeutics AB

The compound annual growth rate of Calliditas Therapeutics AB's revenue for the next 3 years is 57%.

N/A
Past Growth
57%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Calliditas Therapeutics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Net Income
Forecast

Net Income Estimate
Calliditas Therapeutics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CALTX's stock price target?
Not Available

CALTX doesn't have any price targets made by Wall Street professionals.

What is Calliditas Therapeutics AB's Revenue forecast?
Projected CAGR
57%

The compound annual growth rate of Calliditas Therapeutics AB's revenue for the next 3 years is 57%.

Back to Top